News

US PromarkerD patent expanded to all kidney disease

Proteomics International is pleased to announce that the United States patent for its PromarkerD diagnostic test has been expanded to include all kidney disease.

Media release

Subscribe
  • This field is for validation purposes and should be left unchanged.